Avidity Biosciences Inc (RNA)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart

Ticker: RNA Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-04-03	2025-04-01	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	329 -0.6% 27.83 USD 9,155	329 -0.6%	27.83	USD 9,155
2025-04-03	2025-04-01	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	5,546 -9.9% 27.83 USD 154,331	5,546 -9.9%	27.83	USD 154,331
2025-03-21	2025-03-20	PS Planned sale	Boyce Sarah President and CEO Executive Director	31,540 -9.3% 31.06 USD 979,563	31,540 -9.3%	31.06	USD 979,563
2025-03-21	2025-03-20	PS Planned sale	Flanagan W. Michael Chief Scientific Officer Officer	11,780 -12.8% 31.06 USD 365,868	11,780 -12.8%	31.06	USD 365,868
2025-03-21	2025-03-20	PS Planned sale	Hughes Steven George Chief Medical Officer Officer	9,578 -11.6% 31.06 USD 297,491	9,578 -11.6%	31.06	USD 297,491
2025-03-21	2025-03-20	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	7,935 -7.6% 31.06 USD 246,425	7,935 -7.6%	31.06	USD 246,425
2025-03-21	2025-03-20	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	7,778 -7.4% 31.06 USD 241,583	7,778 -7.4%	31.06	USD 241,583
2025-03-12	2025-03-11	PS Planned sale	Flanagan W. Michael Chief Scientific Officer Officer	20,000 -17.9% 30.13 USD 602,614	20,000 -17.9%	30.13	USD 602,614
2025-03-04	2025-03-03	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	5,875 -10.4% 29.41 USD 172,807	5,875 -10.4%	29.41	USD 172,807
2025-02-05	2025-02-03	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	5,875 -10.4% 32.16 USD 188,918	5,875 -10.4%	32.16	USD 188,918
2025-01-23	2025-01-22	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	5,629 -10.0% 30.16 USD 169,776	5,629 -10.0%	30.16	USD 169,776
2025-01-23	2025-01-21	PS Planned sale	Flanagan W. Michael Chief Scientific Officer Officer	1,812 -1.9% 28.59 USD 51,809	1,812 -1.9%	28.59	USD 51,809
2025-01-23	2025-01-21	PS Planned sale	Flanagan W. Michael Chief Scientific Officer Officer	3,860 -4.0% 28.60 USD 110,383	3,860 -4.0%	28.60	USD 110,383
2025-01-23	2025-01-21	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	1,221 -1.2% 28.60 USD 34,917	1,221 -1.2%	28.60	USD 34,917
2025-01-23	2025-01-21	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	1,738 -1.6% 28.59 USD 49,695	1,738 -1.6%	28.59	USD 49,695
2025-01-23	2025-01-21	PS Planned sale	Boyce Sarah President and CEO Executive Director	5,659 -1.6% 28.59 USD 161,817	5,659 -1.6%	28.59	USD 161,817
2025-01-23	2025-01-21	PS Planned sale	Boyce Sarah President and CEO Executive Director	4,738 -1.4% 28.59 USD 135,475	4,738 -1.4%	28.59	USD 135,475
2025-01-23	2025-01-21	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	1,665 -1.6% 28.59 USD 47,608	1,665 -1.6%	28.59	USD 47,608
2025-01-23	2025-01-21	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	1,622 -1.5% 28.59 USD 46,378	1,622 -1.5%	28.59	USD 46,378
2025-01-23	2025-01-21	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	1,872 -12.6% 28.60 USD 53,537	1,872 -12.6%	28.60	USD 53,537
2025-01-23	2025-01-21	PS Planned sale	Hughes Steven George Chief Medical Officer Officer	2,032 -2.4% 28.59 USD 58,096	2,032 -2.4%	28.59	USD 58,096
2025-01-23	2025-01-21	PS Planned sale	Hughes Steven George Chief Medical Officer Officer	1,915 -2.2% 28.60 USD 54,760	1,915 -2.2%	28.60	USD 54,760
2025-01-23	2025-01-21	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	1,817 -3.1% 28.59 USD 51,953	1,817 -3.1%	28.59	USD 51,953
2025-01-23	2025-01-21	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	670 -1.1% 28.60 USD 19,159	670 -1.1%	28.60	USD 19,159
2025-01-23	2025-01-21	PS Planned sale	Gallagher Kathleen P. Chief Program Officer Officer	1,295 -2.2% 28.59 USD 37,024	1,295 -2.2%	28.59	USD 37,024
2024-12-19	2024-12-18	PS Planned sale	Flanagan W. Michael CSTO Officer	12,742 -14.9% 32.66 USD 416,154	12,742 -14.9%	32.66	USD 416,154
2024-12-19	2024-12-18	PS Planned sale	Boyce Sarah President and CEO Executive Director	31,855 -10.7% 32.66 USD 1,040,384	31,855 -10.7%	32.66	USD 1,040,384
2024-12-19	2024-12-18	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	11,151 -11.9% 32.66 USD 364,192	11,151 -11.9%	32.66	USD 364,192
2024-12-19	2024-12-18	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	11,151 -11.9% 32.66 USD 364,192	11,151 -11.9%	32.66	USD 364,192
2024-12-18	2024-12-16	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	25,000 -21.0% 33.26 USD 831,605	25,000 -21.0%	33.26	USD 831,605
2024-12-13	2024-12-11	PS Planned sale	Flanagan W. Michael CSTO Officer	24,000 -21.9% 35.77 USD 858,401	24,000 -21.9%	35.77	USD 858,401
2024-11-20	2024-11-19	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	3,323 -18.3% 42.12 USD 139,973	3,323 -18.3%	42.12	USD 139,973
2024-11-20	2024-11-18	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	25,000 -21.0% 41.14 USD 1,028,520	25,000 -21.0%	41.14	USD 1,028,520
2024-11-08	2024-11-06	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	13,875 -12.9% 45.33 USD 629,008	13,875 -12.9%	45.33	USD 629,008
2024-11-08	2024-11-06	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	65,182 -40.9% 45.33 USD 2,954,954	65,182 -40.9%	45.33	USD 2,954,954
2024-11-08	2024-11-06	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	27,262 -22.5% 46.22 USD 1,260,017	27,262 -22.5%	46.22	USD 1,260,017
2024-10-23	2024-10-21	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 46.63 USD 233,168	5,000 -25.2%	46.63	USD 233,168
2024-10-17	2024-10-16	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	25,000 -21.0% 48.52 USD 1,213,010	25,000 -21.0%	48.52	USD 1,213,010
2024-10-09	2024-10-07	S Sale	Thompson Tamar Non-Executive Director	30,000 -100.0% 44.98 USD 1,349,259	30,000 -100.0%	44.98	USD 1,349,259
2024-10-03	2024-10-01	PS Planned sale	Flanagan W. Michael CSTO Officer	62,500 -42.3% 47.62 USD 2,976,113	62,500 -42.3%	47.62	USD 2,976,113
2024-09-23	2024-09-23	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	11,510 -10.7% 44.00 USD 506,440	11,510 -10.7%	44.00	USD 506,440
2024-09-23	2024-09-23	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	13,153 -16.0% 44.00 USD 578,737	13,153 -16.0%	44.00	USD 578,737
2024-09-23	2024-09-23	PS Planned sale	Boyce Sarah President and CEO Executive Director	32,880 -12.3% 44.00 USD 1,446,723	32,880 -12.3%	44.00	USD 1,446,723
2024-09-23	2024-09-23	PS Planned sale	Flanagan W. Michael CSTO Officer	11,847 -12.2% 43.89 USD 519,996	11,847 -12.2%	43.89	USD 519,996
2024-09-23	2024-09-23	PS Planned sale	Flanagan W. Michael CSTO Officer	13,153 -15.3% 44.00 USD 578,737	13,153 -15.3%	44.00	USD 578,737
2024-09-20	2024-09-19	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 45.73 USD 228,658	5,000 -25.2%	45.73	USD 228,658
2024-09-13	2024-09-11	PS Planned sale	Flanagan W. Michael CSTO Officer	14,894 -19.7% 40.40 USD 601,676	14,894 -19.7%	40.40	USD 601,676
2024-09-13	2024-09-11	PS Planned sale	Flanagan W. Michael CSTO Officer	34,000 -31.0% 40.40 USD 1,373,556	34,000 -31.0%	40.40	USD 1,373,556
2024-09-13	2024-09-11	PS Planned sale	Flanagan W. Michael CSTO Officer	62,500 -45.2% 40.40 USD 2,525,013	62,500 -45.2%	40.40	USD 2,525,013
2024-09-13	2024-09-11	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	25,000 -30.4% 40.40 USD 1,010,043	25,000 -30.4%	40.40	USD 1,010,043
2024-08-21	2024-08-19	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 45.19 USD 225,947	5,000 -25.2%	45.19	USD 225,947
2024-08-07	2024-08-06	PS Planned sale	Boyce Sarah President and CEO Executive Director	28,000 -12.0% 43.35 USD 1,213,822	28,000 -12.0%	43.35	USD 1,213,822
2024-07-23	2024-07-19	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 45.01 USD 225,069	5,000 -25.2%	45.01	USD 225,069
2024-07-11	2024-07-09	PS Planned sale	Boyce Sarah President and CEO Executive Director	28,000 -12.0% 39.93 USD 1,118,082	28,000 -12.0%	39.93	USD 1,118,082
2024-06-21	2024-06-20	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 37.59 USD 187,951	5,000 -25.2%	37.59	USD 187,951
2024-06-20	2024-06-18	PS Planned sale	McCarthy Teresa Chief Human Resources Officer Officer	9,864 -23.5% 39.13 USD 385,972	9,864 -23.5%	39.13	USD 385,972
2024-06-20	2024-06-18	PS Planned sale	Boyce Sarah President and CEO Executive Director	32,074 -18.4% 39.13 USD 1,255,040	32,074 -18.4%	39.13	USD 1,255,040
2024-06-20	2024-06-18	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	11,228 -16.3% 39.13 USD 439,345	11,228 -16.3%	39.13	USD 439,345
2024-06-20	2024-06-18	PS Planned sale	Flanagan W. Michael CSTO Officer	10,106 -16.6% 39.13 USD 395,445	10,106 -16.6%	39.13	USD 395,445
2024-06-14	2024-06-14	PS Planned sale	Boyce Sarah President and CEO Executive Director	35,767 -24.2% 40.08 USD 1,433,484	35,767 -24.2%	40.08	USD 1,433,484
2024-06-14	2024-06-13	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	60,000 -28.1% 40.08 USD 2,404,782	60,000 -28.1%	40.08	USD 2,404,782
2024-06-14	2024-06-13	PS Planned sale	Boyce Sarah President and CEO Executive Director	164,233 -59.4% 40.08 USD 6,581,802	164,233 -59.4%	40.08	USD 6,581,802
2024-06-14	2024-06-12	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	40,000 -15.8% 35.07 USD 1,402,628	40,000 -15.8%	35.07	USD 1,402,628
2024-06-14	2024-06-12	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	104,245 -70.3% 35.72 USD 3,723,141	104,245 -70.3%	35.72	USD 3,723,141
2024-06-14	2024-06-12	PS Planned sale	Boyce Sarah President and CEO Executive Director	100,000 -47.1% 35.73 USD 3,573,020	100,000 -47.1%	35.73	USD 3,573,020
2024-06-05	2024-06-04	PS Planned sale	Boyce Sarah President and CEO Executive Director	28,000 -20.0% 27.42 USD 767,780	28,000 -20.0%	27.42	USD 767,780
2024-05-21	2024-05-20	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 29.90 USD 149,481	5,000 -25.2%	29.90	USD 149,481
2024-05-16	2024-05-14	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	75,000 -63.0% 28.28 USD 2,121,045	75,000 -63.0%	28.28	USD 2,121,045
2024-05-07	2024-05-07	PS Planned sale	Boyce Sarah President and CEO Executive Director	28,000 -20.0% 25.54 USD 715,050	28,000 -20.0%	25.54	USD 715,050
2024-04-22	2024-04-19	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 22.82 USD 114,123	5,000 -25.2%	22.82	USD 114,123
2024-04-03	2024-04-03	S Sale	LEVIN ARTHUR A Non-Executive Director	20,000 -7.3% 27.11 USD 542,214	20,000 -7.3%	27.11	USD 542,214
2024-04-03	2024-04-02	PS Planned sale	Boyce Sarah President and CEO Executive Director	28,000 -20.0% 26.25 USD 734,919	28,000 -20.0%	26.25	USD 734,919
2024-03-21	2024-03-19	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	5,000 -25.2% 23.97 USD 119,848	5,000 -25.2%	23.97	USD 119,848
2024-03-15	2024-03-13	PS Planned sale	MacLean Michael F Chief Financial Officer Officer	40,000 -47.6% 24.52 USD 980,760	40,000 -47.6%	24.52	USD 980,760
2024-03-12	2024-03-12	PS Planned sale	LEVIN ARTHUR A Non-Executive Director	2,641 -15.1% 22.00 USD 58,102	2,641 -15.1%	22.00	USD 58,102

Avidity Biosciences Inc (RNA)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by